Weight Loss. No less than ninety-five percent (95%) participation of all Eligible Enrollees alleging weight loss of more than ten percent (10%) of pre-injury body weight or more than twelve (12) pounds attributable to the use of Olmesartan Products.
Appears in 2 contracts
Sources: Master Settlement Agreement, Master Settlement Agreement